Participants received weekly subcutaneous injections of retatrutide at 0.5 mg, 4.0 mg, 8.0 mg, or 12 mg, placebo, or 1.5 mg dulaglutide over 36 weeks
It is well-tolerated with essentially no side effects, making it an attractive option for patients who prefer non-pharmacological approaches
In the meantime, the new data could still provide guidance to people with diabetes and their doctors, Patell said
While cercariae do not emerge during darkness, low-intensity light could induce a release (100, 101)
Description 5-Amino-1MQ Overview (5-amino-1-methylquinolinium), a structural analogue of methylquinolinium, is a small-molecule inhibitor of the cytosolic enzyme nicotinamide N-methyltransferase (NNMT)